Bagsican, Jebril Raed .

HRN: 22-94-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
09/18/2023
09/24/2023
TOPICAL
-
Q12
T/C Bacterial Conjunctivitis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: